Nikolaeva-Koleva, Magdalena
Butron, Laura
Sempere, Ana
Rivero, Veronica
Fernández-Ballester, Gregorio
Espinosa, Ana
Vergassola, Matteo
Mastrocola, Elena
Zucchi, Sara
Ragni, Lorella
Mangano, Giorgina
Devesa, Isabel
Funding for this research was provided by:
Angelini Pharma S.p.A.
Article History
Accepted: 1 July 2024
First Online: 15 July 2024
Declarations
:
: Within this work we report the identification of proprietary peptides (WO2019238686A1).Angelini Pharma S.p.A. founded this research. MV, EM, SZ and LR are employees of Angelini Pharma. GFB is shareholder of AntalGenics. ID, MNK, AE and AS are employees of AntalGenics. The other authors declare no conflict of interest.